Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress contributes to hair graying and loss as we age.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Moderately high prolactin levels do not cause hair loss in women.

Use PRP and ASC-BT for hair loss and wound healing, but more research needed.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Skin symptoms without a medical cause often reflect psychological stress and are influenced by culture, requiring a team approach for treatment.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

A lotion with minoxidil, hydrocortisone butyrate, and 17a-estradiol can improve or stabilize Frontal Fibrosing Alopecia in some cases, but there's no universally-accepted treatment yet.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

Low-dose acitretin helps nail psoriasis, stem cells may treat scarring alopecia, Chinese men have lower baldness rates, lateral foldplasty is good for ingrown toenails, hair diameter helps diagnose female baldness, childhood trauma linked to alopecia areata, certain hair-weaving leads to scalp conditions in African American women, and new methods for hair research and understanding hair and sweat gland development were introduced.

Ganoderma lucidum extract may help treat stress-related hair loss.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

P-cadherin is crucial for hair follicle pigmentation but not skin pigmentation.

Scaffold-based strategies show promise for regenerating hair follicles and teeth but need more research for clinical use.

Take care of your hair as much as your face for a youthful look.

Hydra can help understand human hair follicle microbiomes and develop new skin disease therapies.

Hemp is a promising ingredient for skin products due to its healing and soothing properties.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.